← Eichor
Study identifier: NCT04873037 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder

Condition: Overactive Bladder Syndrome · Overactive Bladder · Urinary Frequency  ·  Sponsor: Corewell Health East

PhaseNA
Planned participants166
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this clinical trial is to compare the Emsella Chair therapy to Sham and to determine whether electromagnetic technology is effective in the treatment of overactive bladder (OAB). Currently there are no other studies utilizing the Emsella Chair for the treatment of OAB. Eligible subjects will receive 2 treatments per week for a total of 4 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Danielle Tenney  ·  248-551-3565  ·  Danielle.Tenney@corewellhealth.org

Jennifer Giordano, BSN  ·  248-551-3517  ·  Jennifer.Giordano@corewellhealth.org

Always discuss trial participation with your own doctor first.

Locations (1)

Corewell Health William Beaumont University HospitalRoyal Oak, Michigan, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04873037